Opening Recap Market Pulse: Geopolitical tremors out of Tehran dragged benchmarks into cautious territory while tech stocks provided a rare bright spot, leaving overall breadth stuck in neutral. Key Movers: TCS ripped on a big AI...

Company Overview: Embecta Corp. (NASDAQ: EMBC) is a medical device company spun off from Becton, Dickinson and Company in 2022, specializing in diabetes care products – notably insulin syringe and pen needle supplies for insulin...

Opening Recap Market Pulse: Markets opened on a sour note as fresh strikes in Iran rattled sentiment, dragging Sensex and Nifty into the red. Tech names, however, powered a midday rebound, flipping bearish cues into a green tape...

Visa Inc. (NYSE: V) is a global payments technology leader that has recently seen its stock price surge, reflecting strong market momentum. The company operates the world’s largest electronic payments network, benefitting from...

Opening Recap Market Pulse: Asia’s open lagged on Iran’s new strikes, sending Sensex and Nifty sliding in initial trade. By mid-session both benchmarks rallied back near the flatline, buoyed by resilient sectors while the midcap...

Background & Recent Developments Verra Mobility Corporation (NASDAQ: VRRM) – a provider of smart mobility technology solutions – is facing intense scrutiny after a catastrophic stock drop and ensuing legal action. On May 26...

Morning Briefing Market Pulse: Global equities rip higher as Asian tech and European telecoms lead the charge. Key Movers: Alibaba Surges 9% Ahead of Earnings, Baidu Gains 5% as Chinese E-Commerce and Tech Stocks Rally; The $6...

Introduction Nvidia (NASDAQ: NVDA) has seen its stock soar on the back of the AI boom, at one point becoming the world’s most valuable company by market cap (apnews.com). This enthusiasm drove valuation multiples to extreme...

Daily Financial Update Opening Recap Market Pulse: Indian benchmarks regained steam, with Nifty reclaiming the 24,200 zone and midcaps scaling fresh highs while breadth stayed firm despite a pause in IT names. Key Movers: Alibaba...

Overview of Afrezza’s FDA Approval and Market Reaction MannKind Corporation (NASDAQ: MNKD) achieved a long-awaited milestone when the U.S. FDA approved its inhalable insulin Afrezza for adults with Type 1 and Type 2 diabetes (www...